Sahar Nourouzpour

University Health Network

Papers

1

Total Citations

11

H-Index

1

About

Sahar Nourouzpour is a researcher whose work centers on the comparative effectiveness of treatments for non-small cell lung cancer (NSCLC), with a particular focus on minimally invasive interventions. Her major contribution lies in advancing evidence-based comparisons between surgical resection, radiotherapy, and percutaneous thermal ablation for Stage 1 NSCLC. In her highly cited 2022 protocol for a systematic review and network meta-analysis, Nourouzpour systematically evaluates these treatment modalities, addressing the critical need for data on outcomes for medically complex patients who may not be candidates for traditional surgery. This work, with 11 citations, establishes a foundational framework for clinicians weighing the risks and benefits of image-guided ablation against gold-standard surgical approaches. By highlighting the growing role of percutaneous thermal ablation, Nourouzpour’s research directly informs treatment decisions for an aging and more comorbid patient population. Her rigorous methodological approach and focus on network meta-analysis demonstrate a commitment to synthesizing complex clinical evidence, making her a valuable voice in the evolving landscape of lung cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
11
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Surgical resection, radiotherapy and percutaneous thermal ablation for treatment of stage 1 non-small cell lung cancer: protocol for a systematic review and network meta-analysis
11 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University Health Network

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago